TBL: Muscular Dystrophies Flashcards

(97 cards)

1
Q

Group of inherited, progressive muscle diseases in which

there is necrosis of muscle tissue

A

muscular dystrophies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Muscular dystrophies are caused by distinct (blank) in genes affecting proteins found in the cell membrane (sarcolemma), muscle nuclei, ECM, muscle enzymes and contractile proteins.

A

mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

A mutation in dystrophin can lead to one of these two disorders

A

Duchenne’s muscular dystrophy

Becker’s muscular dystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A mutation in laminin-2 can lead to this disorder

A

MDC1A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ancillary tests for muscular dystrophy

A

Creatine kinase levels

MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

X-linked recessive diseases related to dystrophin

A

dystroglycanopathies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The major dystroglycanopathies

A

DMD

BMD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The most common form of muscular dystrophy with an incidence of ~1/3,500 live male births. The mutation rate is about 1/3 of the incidence of the disease in males, or about 1/10,000

A

DMD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Incidence rate of DMD

A

1/3500

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Incidence of BMD

A

1/18,000 to 1/31,000 male births

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
X-linked dilated cardiomyopathy
Isolated quadriceps myopathy
Muscle cramps with myoglobinuria
Asymptomatic elevation of muscle enzymes
Manifesting DMD and BMD carrier females
A

Other dystroglycanopathies that occur at lower incidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

a structural protein which provides integrity to the sarcolemma

A

Dystrophin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The dystrophin gene is on the (blank) chromosome and is a huge gene. What are some kinds of mutations that can cause dystroglycanopathies?

A

X-chromosome; 66% deletions, 5-10% point mutations, 5% duplications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Incidence of DMD vs prevalence

A

1/3500 is the incidence

1/18,000 is the prevalence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What fraction of DMD occurs as a result of spontaneous mutations?

A

1/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do most male children present at birth? When do they begin to have a wide-base, waddling gait and increasing leg weakness and falls?

A

appear normal at birth; these symptoms begin around age 2-6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the clinical sign that is characteristic of DMD?

A

Gower sign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Is weakness worse proximally or distally? In the lower limbs or upper limbs?

A

worse proximally; worse in lower limbs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

By what age do children have difficulty climbing stairs?

By what age are they confined to a wheelchair?

A

8; 12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Development of kyphoscoliosis and joint contractures

The biceps brachii, triceps and quadriceps reflexes diminish and are absent in 50% of children by 10 years of age

Respiratory function gradually declines and leads to death in most patients in their early twenties

Cardiac dysrhythmias and congestive heart failure can occur late in the disease

Central nervous system involvement is involved in DMD.

A

DMD clinical features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is markedly elevated in DMD (50-100X normal) at birth and peaks around 3 y/o

A

serum creatine kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

These two liver enzymes are usually elevated in DMD

A

ALT

AST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What can an MRI reveal in DMD patients?

A

fat and connective tissue replacement in muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What can histology reveal in DMD patients?

A

reduced or absent dystrophin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What can muscle biopsies reveal in DMD patients?
scattered necrotic and regenerating myofibers, variability in myofiber size, increased CT, and small rounded regenerating myofibers
26
Histology of dystrophic tissue will show what three features?
increased connective tissue central nuclei (instead of peripheral) presence of regenerating and degenerating fibers
27
T/F: When comparing DMD and BMD, it is important to quantify the amount of protein in specific tissue and the size of protein.
True
28
Two ways to analyze protein expression in DMD patients
immunohistochemistry | Western blot
29
What is the ultimate diagnostic tool for muscular dystrophy?
gene sequencing
30
Milder form of dystroglycanopathy and can be distinguished from DMD clinically by the slower rate of progression and presence of dystrophin
Becker muscular dystrophy
31
Incidence of BMD?
5/100,000
32
Clinical features that help with diagnosis of BMD
family history compatible with X-linked recessive inheritance ambulation past 15 years of age Limb Girdle pattern of muscle weakness Calf hypertrophy
33
T/F: In BDM, there are cardiac abnormalities similar to DMD, and a reduced life expectancy.
Truth be told!
34
``` What is observed for the following in BMD: Serum CK EMG MRI Histopathology ```
serum CK elevated EMG abnormal MRI can show fatty tissue replacement in affected muscles Histopath similar to DMD, but less severe
35
Immunostaining reveals the presence of dystrophin with (blank) reactive antibodies but not (blank) reactive antibodies (truncated dystrophin protein) in most BMD cases
N-terminal; C-terminal
36
Immunoblot reveals (blank) quantity and (blank) size of dystrophin protein.
abnormal; reduced
37
What happens to women who are carriers of the DMD or BMD gene?
Women who are carriers are normally non-symptomatic, but a few develop muscle weakness- explained by the Lyon hypothesis: skewed X-inactivation of the normal X-chromosome and dystrophin gene
38
T/F: Females with translocations at the chromosomal Xp21 site or Turners may develop dystroglycanopathies
True
39
T/F: Manifesting carriers typically develop a mild limb-girdle phenotype similar to BMD. Laboratory and histologic features of manifesting carriers are similar to DMD and BMD.
That's true..
40
What can be used to treat dystrophinopathies?
corticosteroids!
41
This has been shown to increase muscle strength and function since as early as 10 days and sustained for up to 3 years. Slows the rate of deterioration in children with DMD
Prednisone
42
What's this: weight gain, excessive hair growth, irritability, stunted growth and hyperactivity, increased chance of infection, glucose intolerance, cataract formation, oestoporosis, osteonecrosis, problems with cardiac function
side effects of high doses of corticosteroid treatment
43
This is critical for DMD and BMD patients because of the contractures that develop early in the disease
physical therapy
44
This is a common complication of DMD resulting in pain, aesthetic damage and sometimes ventilator (respiratory) compromise.
scoliosis
45
This is considered with patients exceeding 35° scoliosis and in significant discomfort often improves life quality but does not improve respiratory function.
spinal fusion
46
Genes encoding dystrophin, glycerol kinase (GKD) and Adrenal hypoplasia congenita (DAX1) can occur together as contiguous genes on Chr Xp21. Gene order is Xpter-DAX1-GKD-DMD-centromere. Why is this important?
Depending on the extent of the mutation patients may exhibit combined diseases e.g. children with DMD and GKD exhibit in addition to severe muscle weakness, severe pyschomoter delay, episodic nausea, vomiting and stupor associated with GKD deficiency
47
● Most common form is mutations in Emerin, a nuclear scaffolding protein localized to the inner nuclear membrane, involved in the attachment of heterochromatin ● X-linked recessive ● Wasting and weakness in upper arms, shoulders and legs ● Cardiac complications are frequent and include ventricular myocardial disease and conduction block leading to sudden death. ● Female carriers may develop cardiac dysfunction at older age that can lead to sudden death. There carriers should get regular ECG’s ● CK is elevated. Emerin is found in many tissues therefore skin biopsy can be used in diagnosis and confirmed by DNA testing
Emery-Driefuss muscular dystrophy
48
Emery-Driefuss muscular dystrophy caused by a mutation in (blank).
Emerin
49
Emerin is found in many tissues therefore what procedure can be used in diagnosis and confirmed by DNA testing?
skin biopsy
50
Autosomal dominant forms of Limb-girdle muscular dystrophy have what number in their name? Autosomal recessive forms of Limb-girdle muscular dystrophy have what number in their name?
1; 2
51
Which two forms of Limb-girdle muscular dystrophy are X-linked?
Dystrophin (DMD/BMD) | Emerin (EDMD)
52
Heterogeneous group of disorders that clinically resemble dystroglycanopathies except genes are autosomal
limb-girdle muscular dystrophies
53
Autosomal dominant LGMDs are classified as type (blank), while autosomal recessive are type (blank).
1; 2
54
What is the prevalence of LGMDs?
rare! 8 per million
55
caused by mutations in the myotilin gene
LGMD 1A
56
What does myotilin do?
it's a sarcomeric protein that colocalizes with alpha actinin at the Z-disk
57
caused by mutations in lamin
LGMD 1B
58
What does lamin do?
it is required for nuclear cytoskeleton organization
59
caused by mutations in caveolin-3
LGMD 1C
60
Where is caveolin-3 located? What is it involved in?
located on the sarcolemma; involved in cell signaling and regulation of sodium channels
61
Histopathology of this disease reveals decreased caveoli.
LGMD 1C
62
caused by mutations in the calpain-3 gene
LGMD 2A
63
This LGMD has a normal life expectancy
LGMD 2A
64
What can be used to test for calpainopathies?
Western Blot
65
What is a classic clinical feature of LGMD 2A, or calpainopathy?
winged scapula
66
Caused by mutations in the dysferlin gene
LGMD 2B | Miyoshi Myopathy
67
Both LGMD2B and Miyoshi Myopathy are caused by mutations in dysferlin. They are both autosomal recessive. Adult-onset, slowly progressive. So what distinguished them from one another?
LGMD2B presents as muscle weakness in proximal lower girdle muscles Miyoshi Myopathy presents as muscle weakness in calf muscles
68
How can you remember that Miyoshi Myopathy is just in the calf muscles?
Think of a weenie little Asian boy with no calves
69
● Onset 1st-3rd decade ● Loss of ambulation 2nd-4th decade ● CK markedly  ● Cardiac involvement
sarcoglycanopathies
70
Mutations in any of the four sarcoglycan genes can cause LGMD2C, LGMD2D, LGMD2E and LGMD2F. All are autosomal recessive
sarcoglycanopathies
71
T/F: The sarcoglycans are a tightly associated protein complex and loss of one member of the complex often results in loss or reduced levels of the others making exact diagnosis tricky
True
72
Account for >10% of patients with a limb-girdle pattern and positive dystrophin
sarcoglycanopathies
73
T/F: In sarcoglycanopathies, disease severity is dependent on which protein is absent.
True
74
In this disease, the onset is variable. Wide range of phenotypes. Commonest form in UK/Germany. Calf/leg/tongue hypertrophy. Increased CK, risk of cardiomyopathy and respiratory failure.
LGMD 2I - FKRP
75
Calf hypertrophy is present in all forms of LGMD except which?
2B (dysferlin)
76
Which two LGMDs have cardiac involvement? In which is it rare?
sarcoglycan and FKRP | rare in calpain and dysferlin deficiency
77
Which LGMDs have DMD-like phenotype?
sarcoglycan, FKRP, and calpain
78
Which LGMD has a range of phenotypes?
FKRP
79
Clinical presentation of congenital muscular dystrophies? Pathology
hypotonia, weakness, onset at birth to 6 months, increased CK pathology: dystrophic biopsy
80
What is a congenital muscular dystrophy which is merosin deficient and causes no or minor brain abnormalities?
MDC1A
81
Caused by mutations in the LAMA2 gene
MDC1A
82
What protein is completely or partially absent in MDC1A?
laminin 211 and 221 (merosin)
83
Severe weakness of the trunk and limbs and hypotonia at birth Prominent contractures of the feet and hips are present Although intelligence is normal, the incidence of epilepsy is 12% to 20% Brain MRI can reveal increased signal in the white matter on T2-weighted images. Computed tomography (CT) of the head reveals lucencies of the white matter.
MDC1A
84
Selenoprotein N disorders are associated with two autosomal recessive conditions
multi-mini core disease | rigid spine syndrome
85
Two Collagen VI muscular dystrophies. Which is mild, which is severe?
Bethlem myopathy is mild, Ullrich Congenital MD is severe
86
Which collagen VI muscular dystrophy is associated with contractures and distal laxity?
Ullrich
87
Dystroglycanopathies are associated with major brain abnormalities. List three of em.
Fukuyama Muscle Eye Brain Disease Walker Warburg syndrome
88
This is a severe dystroglycanopathy, detected on early antenatal ultrasound, encephalocoeles frequent, type II lissencephaly
Walker Warburg Syndrome
89
Problem gene POMT1 which codes for O-mannosyltransferase and the glycosylation of alpha-dystroglycan
Walker Warburg Syndrome
90
Problem gene POMGnT1, seen in all populations, secondary merosin and alpha DG deficiency
Muscle eye brain disease
91
Severe phenotype clinically and histopathologically generalised leg hypertrophy, macroglossia Increased CK, (N) brain, (N) intellect, (N) NCS LGMD2I - allelic variant - most common LGMD in UK (>20%) dilated cardiomyopathy very common
MDC1C - FKRP
92
Mutations in the Fukutin gene. Autosomal recessive.
Fukuyama congenital muscular dys
93
What is Fukutin involved in?
Fukutin is a glycosyl transferase and is involved in the glycosylation of alpha-dystroglycan
94
Patients are typically of Japanese origin It is a homozygous founder mutation Pts die by avg age 16 Heterozygous for a point mutation
Fukuyama CMD
95
Characterized by progressive muscle wasting and weakness and myotonia. Caused by mutations in myotonic dystrophy protein kinase gene. CTG repeats expand into the hundreds or thousands, and the mutation shows anticipation. Typical presentation is early teenage onset, weakness in hands and distal muscles and footdrop. Long face with mournful expression
myotonic dystrophy type 1
96
Characterized by progressive muscle wasting and weakness and myotonia. Allelic disorder. Caused by CCTG expansion. Most people manifest disease between 20-60 y/o. Starts with pain and stiffness in thigh muscles. Anticipation is milder.
myotonic dystrophy type 2 or PROMM
97
Autosomal dominant MD caused by a deletion in a repeating sequence D4Z4. When this region is hypomethylated it causes a myopathy. Expression of DUX4 gene is responsible. Severity of disease depends on size of deletion.
Facioscapulohumeral dystrophy